ConductScience.org, home

Paper33015641

Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19.

Bovijn J and 2 others. Lancet Rheumatol, 2020. Cited by 62 papers, by iCite.

Cite this record

ConductScience Library. Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19. Papers, record 33015641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33015641

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19.
PubMed
Journal
Lancet Rheumatol
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
62
iCite
Relative citation ratio, by iCite
2.25
iCite
Revised in PubMed
2025-05-30
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bovijn JJonas
2Lindgren CMCecilia M
3Holmes MVMichael V

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
FS/18/23/33512British Heart FoundationUnited KingdomPubMed
MC_UU_12026/2Medical Research CouncilUnited KingdomPubMed
MC_PC_14135Medical Research CouncilUnited KingdomPubMed
MC_UU_00017/1Medical Research CouncilUnited KingdomPubMed
MC_PC_13049Medical Research CouncilUnited KingdomPubMed

Source PubMed

Download CSV of grants

References4

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122421340The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.Lancet2012https://conductscience.org/library/papers/22421340PubMed
232397738Interleukin-6 Signaling Effects on Ischemic Stroke and Other Cardiovascular Outcomes: A Mendelian Randomization Study.Circ Genom Precis Med2020https://conductscience.org/library/papers/32397738PubMed
332404885The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic.Eur J Hum Genet2020https://conductscience.org/library/papers/32404885PubMed
432838323Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study.Lancet Rheumatol2020https://conductscience.org/library/papers/32838323PubMed

Download CSV of references

Cited by46

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.

PMIDTitleJournalYearIn PapersSource
42009889Repurposing drugs for the prevention of vascular dementia using evidence from drug target Mendelian randomization.Nat Aging2026https://conductscience.org/library/papers/42009889PubMed
41969525Neuropeptide and cytokines expression in long COVID-19 related neuropsychological sequelae: insights into NK1R-mediated neuroinflammation and in silico therapeutic targeting.Front Cell Neurosci2026https://conductscience.org/library/papers/41969525PubMed
41961272Proteome-wide Mendelian randomization identifies APOM and TNXB as actionable mediators of steroid-sensitive nephrotic syndrome.Pediatr Nephrol2026https://conductscience.org/library/papers/41961272PubMed
41593342Explainable AI multiomics analysis reveals shared and divergent host responses in COVID-19 and influenza.NPJ Digit Med2026https://conductscience.org/library/papers/41593342PubMed
41402665Human genetics implicate thromboembolism in the pathogenesis of long COVID in individuals of European ancestry.Nat Cardiovasc Res2025https://conductscience.org/library/papers/41402665PubMed
40718904Human Genetics Informing Drug Development in Cardiovascular Disease: Interleukin-6 Signaling as a Case Study.Circ Genom Precis Med2025https://conductscience.org/library/papers/40718904PubMed
39944268Drug-target Mendelian randomisation applied to metabolic dysfunction-associated steatotic liver disease: opportunities and challenges.eGastroenterology2024https://conductscience.org/library/papers/39944268PubMed
39622956Identification of immune-related hub genes and potential molecular mechanisms involved in COVID-19 via integrated bioinformatics analysis.Sci Rep2024https://conductscience.org/library/papers/39622956PubMed
39379679Disease coverage of human genome-wide association studies and pharmaceutical research and development.Commun Med (Lond)2024https://conductscience.org/library/papers/39379679PubMed
39172202Causal factors for osteoarthritis risk revealed by mendelian randomization analysis.Aging Clin Exp Res2024https://conductscience.org/library/papers/39172202PubMed
39062668Pathway-Based Mendelian Randomization for Pre-Infection IL-6 Levels Highlights Its Role in Coronavirus Disease.Genes (Basel)2024https://conductscience.org/library/papers/39062668PubMed
38898459Genetic perturbation of IL-6 receptor signaling pathway and risk of multiple respiratory diseases.J Transl Med2024https://conductscience.org/library/papers/38898459PubMed
38789577CytoSIP: an annotated structural atlas for interactions involving cytokines or cytokine receptors.Commun Biol2024https://conductscience.org/library/papers/38789577PubMed
38550933Mendelian randomization as a tool to inform drug development using human genetics.Camb Prism Precis Med2023https://conductscience.org/library/papers/38550933PubMed
38198221PCSK9 genetic variants and risk of vascular and non-vascular diseases in Chinese and UK populations.Eur J Prev Cardiol2024https://conductscience.org/library/papers/38198221PubMed
38099246Host Genetic Impact on Infectious Diseases among Different Ethnic Groups.Adv Genet (Hoboken)2023https://conductscience.org/library/papers/38099246PubMed
37515388Germline mechanisms of immunotherapy toxicities in the era of genome-wide association studies.Immunol Rev2023https://conductscience.org/library/papers/37515388PubMed
37464031Biological and functional multimorbidity-from mechanisms to management.Nat Med2023https://conductscience.org/library/papers/37464031PubMed
36805566Proteome-wide Mendelian randomization implicates nephronectin as an actionable mediator of the effect of obesity on COVID-19 severity.Nat Metab2023https://conductscience.org/library/papers/36805566PubMed
36801374The effect of interleukin-6 signaling on severe malaria: A Mendelian randomization analysis.Int J Infect Dis2023https://conductscience.org/library/papers/36801374PubMed

See all 46 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CRP1401PubTator's text mininghttps://conductscience.org/library/genes/1401NCBI Gene
FGB2244PubTator's text mininghttps://conductscience.org/library/genes/2244NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
IL6R3570PubTator's text mininghttps://conductscience.org/library/genes/3570NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33015641

GET https://conductscience.org/api/papers/v1/33015641/cited_by?page=2